1st Apr 2010 13:55
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of changes in the directors' interests in the Ordinary shares and American Depository Shares (ADSs) of GlaxoSmithKline plc.
On 31 March 2010, the Company's Non-Executive Directors were provisionally allocated awards over Ordinary shares at a price of £12.67 per Ordinary share and $38.29 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 January 2010 to 31 March 2010:
|
Non Executive Director |
Ordinary Shares |
American Depository Shares (ADSs) |
|
Sir Christopher Gent |
2,663.77 |
|
|
Prof. Sir Roy Anderson |
813.93 |
|
|
Dr Stephanie Burns |
|
399.73 |
|
Mr Lawrence Culp |
|
799.46 |
|
Sir Crispin Davis |
3,058.41 |
|
|
Sir Deryck Maughan |
|
799.46 |
|
Mr James Murdoch |
2,663.77 |
|
|
Dr Daniel Podolsky |
|
839.43 |
|
Mr Tom de Swaan |
1,060.58 |
|
|
Sir Robert Wilson |
813.93 |
|
The Company and the Non-Executive Directors were informed of these allocations on 1 April 2010.
This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
S M Bicknell
Company Secretary
1 April 2010
Related Shares:
Glaxosmithkline